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ABSTRACT: Manganese superoxide dismutase (Mn-
SOD) is the most effective antioxidant enzyme in mi-
tochondria and protects cells from reactive oxygen
species-induced oxidative damage. The aim of this
study was to investigate the association between Mn-
SOD Ala-9Val gene polymorphism and prostate can-
cer (PCa) risk in Turkish men with prostate cancer. 33
patients with PCa and 81 control individuals were in-
cluded in the study. We observed an association be-
tween MnSOD Ala/Ala frequency and a higher PCa
risk. In addition, we found that the increased risk
of early-onset PCa (under age of 65) in the men ho-
mozygous for Ala allele was higher than the men ho-
mozygous for Val allele. However, we determined that
MnSOD Ala-9Val genotype was not associated with
the aggressiveness of the disease. The results of our
study suggest that MnSOD Ala/Ala genotype may in-
fluence on early-onset of PCa patients, but no effect
on subsequent development of the disease in Turk-
ish men. However, our study has a limitation that is
small numbers of individuals for cases and controls.
Therefore, the presented study limited our statistical
power to fully investigate the gene polymorphism on
cancer risk. C© 2013 Wiley Periodicals, Inc. J Biochem
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INTRODUCTION
Manganese superoxide dismutase (MnSOD) is the
most effective antioxidant enzyme in mitochondria [1]
and has an important role in protecting cells from reac-
tive oxygen species (ROS)–induced oxidative damage
[2, 3]. It has been suggested that MnSOD (Ala-9Val)
gene polymorphism may alter the secondary structure
of the protein [4–6] and affects transport of MnSOD
enzyme into the mitochondria [7, 8].
It has been indicated that the Ala-containing Mn-
SOD is transported more efficiently through the mito-
chondrial membrane, suggesting that the individuals
with the homozygous AA genotype may have higher
MnSOD activity in comparison with those with the
Val/Val and Val/Ala genotype [9,10]. The MnSOD Ala
variant showed normal transport and generated 30–
40% more active protein than did the Val variant in
mitochondria [7]. Since the superoxide anion is dismu-
tated by MnSOD, a potential source of oxidative dam-
age, one can predict that the MnSOD Val allele (but not
the Ala allele) may lead to an increased risk of cancer.
However, if some individuals have decreased capacity
to remove hydrogen peroxide by enzymes of catalase
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